Literature DB >> 33301354

Experiences of Mental Health Clinicians and Staff in Rapidly Converting to Full-Time Telemental Health and Work from Home During the COVID-19 Pandemic.

Dana Steidtmann1,2, Samantha McBride1,2, Matthew C Mishkind1,2,3.   

Abstract

Background: The mitigation strategies for the COVID-19 pandemic pushed much of the mental health workforce to rapidly convert to full-time telemental health (TMH). For many people, this occurred in the context of working from makeshift home offices with novel distractions. We describe the results of an online survey of mental health clinicians and staff regarding their experiences in rapidly converting to full-time TMH and work from home (WFH) during COVID-19.
Methods: Fourteen clinicians and 11 administrative staff from two outpatient mental health clinics in a large academic medical center completed the survey in May 2020.
Results: More than 85% of participants rated the experience of providing or supporting full-time TMH care as "somewhat better" or "much better than expected." Clinicians and administrative staff reported perceptions that most clients were satisfied with TMH services. Identified TMH challenges included difficulty providing clinical forms and difficulties with technology. Identified benefits of WFH included lack of commute, time with loved ones, opportunities for self-care, and increased flexibility. Maintaining team cohesion and communication while working remotely, and setting boundaries between work and nonwork hours were identified as challenges. Nearly all respondents indicated a preference to continue some TMH from home in the future. Conclusions: Findings suggest that rapidly adopting TMH and WFH during a pandemic were well accepted. Should the progression of the pandemic require agile movement in and out of TMH and WFH, overcommunication and extra attention to supporting employee connection and morale are especially important.

Entities:  

Keywords:  behavioral health; pandemic; psychology; telehealth; telemedicine; telepsychiatry

Year:  2020        PMID: 33301354     DOI: 10.1089/tmj.2020.0305

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  6 in total

1.  The Good, The Bad, The Uncertain: Diverse Provider Experiences with Telemental Health During COVID-19.

Authors:  Jessica L Lawson; Jennifer M Doran; McKenna O'Shea; Erica A Abel
Journal:  Psychiatr Q       Date:  2022-06-11

2.  Behavioral healthcare organizations' experiences related to use of telehealth as a result of the COVID-19 pandemic: an exploratory study.

Authors:  Abby Kisicki; Sara Becker; Michael Chaple; David H Gustafson; Bryan J Hartzler; Nora Jacobson; Ann A Murphy; Stephanie Tapscott; Todd Molfenter
Journal:  BMC Health Serv Res       Date:  2022-06-13       Impact factor: 2.908

3.  Power on: The rapid transition of a large interdisciplinary behavioral health department to telemental health during the COVID-19 pandemic.

Authors:  S L Harding; M Eyllon; A Twigden; A Hogan; D Barry; J E Mirsky; B Barnes; S Nordberg
Journal:  J Interprof Educ Pract       Date:  2022-02-24

4.  Impact of COVID-19 Mitigation Efforts on Adults With Serious Mental Illness: A Patient-Centered Perspective.

Authors:  Ivy Benjenk; Zeina Saliba; Neel Duggal; Asmaa Albaroudi; Jacqueline Posada; Jie Chen
Journal:  J Nerv Ment Dis       Date:  2021-12-01       Impact factor: 2.254

5.  Health policy experts' perspectives on implementing mental health specialist video consultations in routine primary care - a qualitative interview study.

Authors:  Justus Tönnies; Lydia Oeljeklaus; Michel Wensing; Mechthild Hartmann; Hans-Christoph Friederich; Markus W Haun
Journal:  BMC Health Serv Res       Date:  2021-07-20       Impact factor: 2.655

6.  LeiP#netz 2.0: mapping COVID-19-related changes in mental health services in the German city of Leipzig.

Authors:  Gesa Solveig Duden; Stefanie Gersdorf; Kai Trautmann; Ingmar Steinhart; Steffi Riedel-Heller; Katarina Stengler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-03-25       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.